Title : Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients.

Pub. Date : 2020

PMID : 32390827






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CYP2C9 *2 or *3 carriers were associated with increased clearance of CPA. Cyclophosphamide cytochrome P450 family 2 subfamily C member 9 Homo sapiens
2 CYP3A5 and CYP2C9 genotypes, BSA, BMI, and CPA dosage regimen influence PK of CPA. Cyclophosphamide cytochrome P450 family 2 subfamily C member 9 Homo sapiens
3 CYP3A5 and CYP2C9 genotypes, BSA, BMI, and CPA dosage regimen influence PK of CPA. Cyclophosphamide cytochrome P450 family 2 subfamily C member 9 Homo sapiens